Professional Summary

Professional Overview

Brian Kriete is an accomplished Chief Financial Officer with extensive experience in the healthcare and professional services industries. He excels at financial management, strategic planning, and leading cross-functional teams to drive operational efficiency and profitability.

Current Role

As the Chief Financial Officer at AOM Infusion, Brian is responsible for overseeing all financial activities, including budgeting, forecasting, cash flow management, and financial reporting. He plays a crucial role in aligning the company's financial strategies with its overall business objectives, ensuring sound decision-making and sustainable growth.

Career Progression

Prior to his current role, Brian served as the Vice President of Finance & Integration at Solis Mammography, where he spearheaded the integration of acquired entities, streamlined financial processes, and implemented cost-saving initiatives that improved the organization's bottom line. Before that, he held positions as the Director of Corporate Finance at US Anesthesia Partners and the Director of Corporate Treasury at Contran Corporation, where he demonstrated exceptional financial acumen and strategic leadership.

Academic Background

Brian holds a Bachelor of Business Administration degree in Accounting from the University of Texas at Dallas, where he graduated with honors. He is a Certified Public Accountant (CPA) and has completed several professional development programs in financial management and strategic leadership.

Areas of Expertise

• Financial management and reporting

• Budgeting and forecasting

• Cash flow optimization

• Mergers and acquisitions integration

• Financial process improvement

• Strategic planning and decision-making

• Leadership and team development

Professional Impact

Throughout his career, Brian has played a pivotal role in driving financial performance and operational excellence. At Solis Mammography, he led the integration of four acquired entities, resulting in a 20% reduction in administrative costs and a 15% increase in profitability. At US Anesthesia Partners, he spearheaded the implementation of a new financial reporting system, which improved data visibility and enabled more informed decision-making.

Conclusion

With his strong financial expertise, strategic mindset, and proven track record of success, Brian Kriete is poised to continue making a significant impact as the Chief Financial Officer at AOM Infusion. He is committed to leveraging his skills and experience to support the company's growth, optimize financial performance, and contribute to its long-term sustainability.